At the request of Annexin Pharmaceuticals, Annexin Pharmaceuticals equity rights will be traded on First North as from June 27, 2018.
| Security name: | Annexin Pharmaceuticals TO2 |
| Short name: | ANNX TO2 |
| ISIN code: | SE0011090232 |
| Orderbook ID: | 157038 |
| Terms: | Issue price, 4,40 SEK per share |
| - |
1 option right gives the right to subscribe for 1 new share in Annexin Pharmaceuticals |
| Subscription period: | March 4,2019 - March 15, 2019 |
| Last trading day: | March 13, 2019 |
This information is distributed at the request of the Certified Adviser, Redeye AB. For further information, please call Andreas Eriksson on +46 (0)8 545 013 30.